JFG
ABBV icon

Jefferies Financial Group’s AbbVie ABBV Stock Holding History

Jefferies Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.5M Buy
268,264
+59,905
+29% +$12.9M 0.44% 33
2026
Q1 		$45.3M Buy
208,359
+104,902
+101% +$23.3M 0.31% 49
2025
Q4 		$23.6M Buy
103,457
+3,784
+4% +$862K 0.12% 170
2025
Q3 		$23.1M Sell
99,673
-53,123
-35% -$10.8M 0.11% 141
2025
Q2 		$28.4M Sell
152,796
-26,832
-15% -$4.99M 0.24% 86
2025
Q1 		$37.6M Buy
179,628
+122,214
+213% +$23.8M 0.33% 49
2024
Q4 		$10.2M Sell
57,414
-246,037
-81% -$45.2M 0.06% 220
2024
Q3 		$59.9M Buy
303,451
+23,730
+8% +$4.43M 0.43% 34
2024
Q2 		$48M Buy
279,721
+216,167
+340% +$35.8M 0.51% 27
2024
Q1 		$11.6M Buy
+63,554
New +$11M 0.11% 149
2023
Q4 		– Sell
-19,562
Closed -$2.92M – 1644
2023
Q3 		$2.92M Sell
19,562
-1,078
-5% -$158K 0.03% 497
2023
Q2 		$2.78M Sell
20,640
-136,480
-87% -$20M 0.02% 545
2023
Q1 		$25M Buy
157,120
+66,801
+74% +$10.2M 0.2% 83
2022
Q4 		$14.6M Buy
+90,319
New +$13.8M 0.1% 162
2019
Q2 		– Sell
-17,028
Closed -$1.37M – 14
2019
Q1 		$1.37M Sell
17,028
-23,777
-58% -$1.95M 0.14% 20
2018
Q4 		$3.76M Buy
40,805
+725
+2% +$63.8K 0.44% 15
2018
Q3 		$3.79M Buy
40,080
+7,551
+23% +$716K 0.31% 40
2018
Q2 		$3.01M Buy
+32,529
New +$3.18M 0.23% 47
2018
Q1 		– Sell
-5,109
Closed -$494K – 75
2017
Q4 		$494K Buy
+5,109
New +$481K 0.04% 67
2017
Q2 		– Sell
-8,008
Closed -$522K – 55
2017
Q1 		$522K Buy
+8,008
New +$503K 0.04% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jefferies Financial Group's ABBV Position: Q2 2026 in Review

Jefferies Financial Group increased its AbbVie (ABBV) stake by 29% in Q2 2026, buying an estimated $12.9M and bringing the position to 268,264 shares worth $67.5M. The position accounts for 0.44% of the portfolio, ranked #33.

Jefferies Financial Group first reported a position in ABBV in Q1 2017 and has held it in 20 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Jefferies Financial Group held 268,264 shares of AbbVie worth $67.5M as of Q2 2026.
  • Jefferies Financial Group bought 59,905 AbbVie shares in Q2 2026, an estimated $12.9M.
  • AbbVie made up 0.44% of Jefferies Financial Group's portfolio in Q2 2026, its #33 holding.
  • Jefferies Financial Group first reported a position in AbbVie in Q1 2017 and has held it in 20 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.